S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
pixel
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
pixel
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
pixel
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
pixel
Log in
NASDAQ:PTE

PolarityTE Stock Forecast, Price & News

$1.05
-0.03 (-2.78 %)
(As of 01/22/2021 12:00 AM ET)
Add
Compare
Today's Range
$1.03
Now: $1.05
$1.09
50-Day Range
$0.61
MA: $0.82
$1.32
52-Week Range
$0.55
Now: $1.05
$4.03
Volume10.64 million shs
Average Volume18.41 million shs
Market Capitalization$41.20 million
P/E RatioN/A
Dividend YieldN/A
Beta1.29
PolarityTE, Inc., a biotechnology and regenerative biomaterials company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine and Contract Services. It offers SkinTE, a tissue product for treatment of defects of the skin, as well as contract research services; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; and PTE 11000, an allogenic, biologically active dressing for use in wound care and aesthetics to accelerate healing of skin. The company also develops OsteoTE, an autologous homologous bone regeneration product; and CartTE, an autologous cartilage regeneration product. In addition, it develops AdipoTE to optimize the delivery of autologous fat; AngioTE for vascular regeneration; NeuralTE for peripheral nerve injuries of the extremities, as well as for patients with neuromas or chronic compression due to joint replacements, migraines, craniofacial injuries, carpal tunnel syndrome, and those who have undergone hernia or abdominal-based procedures; UroTE for the delivery of autologous urogenital epithelium and submucosa; LiverTE to address various causes of liver failure; and BowelTE to deliver an optimized autologous construct to aid in the regeneration of bowel tissue. PolarityTE, Inc. was incorporated in 1998 and is headquartered in Salt Lake City, Utah.

MarketRank

Overall MarketRank

1.44 out of 5 stars

Medical Sector

499th out of 1,925 stocks

Biological Products, Except Diagnostic Industry

67th out of 177 stocks

Analyst Opinion: 3.3Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PTE
CUSIPN/A
CIKN/A
Phone385-237-2279
Employees153

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$5.65 million
Book Value$1.42 per share

Profitability

Net Income$-92,490,000.00
Net Margins-674.12%

Miscellaneous

Market Cap$41.20 million
Next Earnings Date3/11/2021 (Estimated)
OptionableOptionable
$1.05
-0.03 (-2.78 %)
(As of 01/22/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PTE News and Ratings via Email

Sign-up to receive the latest news and ratings for PTE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











PolarityTE (NASDAQ:PTE) Frequently Asked Questions

How has PolarityTE's stock price been impacted by Coronavirus?

PolarityTE's stock was trading at $1.07 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, PTE shares have decreased by 1.9% and is now trading at $1.05.
View which stocks have been most impacted by COVID-19
.

Is PolarityTE a buy right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PolarityTE in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" PolarityTE stock.
View analyst ratings for PolarityTE
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than PolarityTE?

Wall Street analysts have given PolarityTE a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but PolarityTE wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Doug Parker's approval rating as PolarityTE's CEO?

1,448 employees have rated PolarityTE CEO Doug Parker on Glassdoor.com. Doug Parker has an approval rating of 60% among PolarityTE's employees. This puts Doug Parker in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

When is PolarityTE's next earnings date?

PolarityTE is scheduled to release its next quarterly earnings announcement on Thursday, March 11th 2021.
View our earnings forecast for PolarityTE
.

How were PolarityTE's earnings last quarter?

PolarityTE, Inc. (NASDAQ:PTE) posted its quarterly earnings results on Monday, November, 9th. The company reported ($0.18) EPS for the quarter, beating analysts' consensus estimates of ($0.21) by $0.03. The business earned $3.34 million during the quarter, compared to the consensus estimate of $3.30 million. PolarityTE had a negative net margin of 674.12% and a negative return on equity of 169.92%. During the same period in the prior year, the firm posted ($0.87) EPS.
View PolarityTE's earnings history
.

What price target have analysts set for PTE?

4 brokerages have issued 12-month target prices for PolarityTE's stock. Their forecasts range from $3.00 to $5.00. On average, they expect PolarityTE's share price to reach $4.00 in the next twelve months. This suggests a possible upside of 281.0% from the stock's current price.
View analysts' price targets for PolarityTE
or view Wall Street analyst' top-rated stocks.

Are investors shorting PolarityTE?

PolarityTE saw a decline in short interest in the month of December. As of December 31st, there was short interest totaling 1,380,000 shares, a decline of 48.9% from the December 15th total of 2,700,000 shares. Based on an average trading volume of 1,200,000 shares, the short-interest ratio is presently 1.2 days. Currently, 5.6% of the shares of the company are short sold.
View PolarityTE's Short Interest
.

Who are some of PolarityTE's key competitors?

What other stocks do shareholders of PolarityTE own?

Who are PolarityTE's key executives?

PolarityTE's management team includes the following people:
  • Mr. David B. Seaburg, Chief Exec. Officer (Age 50, Pay $280.16k)
  • Mr. Richard Hague, Pres & COO (Age 60, Pay $377.54k)
  • Mr. Jacob Alexander Patterson, Interim Chief Financial Officer (Age 42)
  • Mr. Nikolai Sopko, Chief Scientific Officer and VP of R&D
  • Mr. Rich Haerle, VP of Investor Relations & Strategy
  • Mr. Cameron J. Hoyler, Gen. Counsel, Sec. and Exec. VP of Corp. Devel. & Strategy (Age 36)
  • Angela Ziegler, VP of Marketing & PR
  • Mr. Alain Adam, VP of Sales
  • Dr. Edward Winslow Swanson, Chief Medical Officer & Co-Founder (Age 35)
  • Dr. Stephen Milner M.D., DDS, DSc, FRCSE, FACS, Chief Clinical Officer & Member of Clinical Advisory Board (Age 71)

What is PolarityTE's stock symbol?

PolarityTE trades on the NASDAQ under the ticker symbol "PTE."

Who are PolarityTE's major shareholders?

PolarityTE's stock is owned by a variety of retail and institutional investors. Top institutional investors include LWS Wealth Advisors Inc. (0.21%). Company insiders that own PolarityTE stock include Cameron J Hoyler, David B Seaburg, Denver Lough, Edward Winslow Swanson, Jeffrey Hansen Dyer, Paul Elliot Mann, Peter A Cohen, Rainer M Erdtmann, Richard Hague and Steve Gorlin.
View institutional ownership trends for PolarityTE
.

Which major investors are buying PolarityTE stock?

PTE stock was bought by a variety of institutional investors in the last quarter, including LWS Wealth Advisors Inc.. Company insiders that have bought PolarityTE stock in the last two years include Edward Winslow Swanson, Paul Elliot Mann, and Peter A Cohen.
View insider buying and selling activity for PolarityTE
or or view top insider-buying stocks.

How do I buy shares of PolarityTE?

Shares of PTE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is PolarityTE's stock price today?

One share of PTE stock can currently be purchased for approximately $1.05.

How big of a company is PolarityTE?

PolarityTE has a market capitalization of $41.20 million and generates $5.65 million in revenue each year. The company earns $-92,490,000.00 in net income (profit) each year or ($3.70) on an earnings per share basis. PolarityTE employs 153 workers across the globe.

What is PolarityTE's official website?

The official website for PolarityTE is www.polarityte.com.

How can I contact PolarityTE?

PolarityTE's mailing address is 123 NORTH WRIGHT BROTHERS DRIVE, SALT LAKE CITY UT, 84116. The company can be reached via phone at 385-237-2279 or via email at [email protected]

This page was last updated on 1/24/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.